ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: drug combo trial targets relapsed cases in kids
Disease control OngoingThis early-phase trial tests a new combination of drugs (ribociclib, everolimus, and dexamethasone) in children and young adults up to age 30 whose acute lymphoblastic leukemia has come back or not responded to standard treatments. The goal is to find the safest dose and see how …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Lab-Made donor cells aim to beat cancer without the side effects
Disease control OngoingThis study is for children and young adults up to age 21 with high-risk blood cancers like leukemia or lymphoma. It tests a transplant using specially treated donor cells from a family member to reduce the risk of the cancer coming back while lowering the chance of a serious side…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 18, 2026 12:07 UTC